GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

User: Guest

Title:: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
Document type:: Zeitschriftenaufsatz
Author(s):: Sachs, Stephan ; Götz, Anna ; Finan, Brian ; Feuchtinger, Annette ; DiMarchi, Richard D. ; Döring, Yvonne ; Weber, Christian ; Tschöp, Matthias H. ; Müller, Timo D. ; Hofmann, Susanna M.
Keywords:: Research ; Novel Cardioprotective Antidiabetic Medications ; GIP agonist ; acyl-GIP ; Obesity ; Dyslipidemia ; Atherosclerosis ; Cardiometabolic disease ; Mice ; Medical and Health Sciences
Journal title:: Cardiovascular Diabetology
Year:: 2023
Journal volume:: 22
Journal issue:: 1
Fulltext / DOI:: doi:10.1186/s12933-023-01940-2
Publisher:: BioMed Central
E-ISSN:: 1475-2840
Date of publication:: 17.08.2023
BibTeX

Occurrences: